Nonrulemaking

Requests that the FDA declare that an ANDA may be submitted for, Modafinil Tablets, USP 50 mg and 150 mg, 2 strengths that differ from the currently approved RLD, PROVIGIL (Modafinil) tablets from NUVO PHARMACEUTICALS (IRELAND) DAC, which FDA approved in 100 mg and 200 mg strengths on Dec 24th, 1998 under NDA #020717.

Documents
6
Total comments
0
all analyzed
Comment status
Open
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

📄 Primary document
OtherJul 1, 2026
Completeness Assessment Correspondence
No comment period
Open →